Lipid emulsion therapy - Intralipid
โ ๏ธ Evidence base: There is a lack of controlled trials, and efficacy remains uncertain. Use is based on case reports and expert consensus.
โน๏ธ About
Always check the BNF link here ๐ for the latest guidance.
โ๏ธ Mode of Action
- Intravenous fat emulsion (IFE, e.g. Intralipid 20%) acts as a "lipid sink," sequestering lipid-soluble drugs from target tissues (heart, brain) and improving mitochondrial metabolism.
- Used for life-threatening arrhythmias or cardiac arrest due to lipophilic drug toxicity, especially local anaesthetics.
๐ Indications & Dose
- Indication: Severe toxicity from local anaesthetics (e.g. bupivacaine) or other lipid-soluble cardiotoxic drugs.
- Initial bolus: 1.5 mL/kg IV over 1 min (โ100 mL for a 65 kg adult).
- Infusion: Follow with 0.25 mL/kg/min; continue CPR if pulseless for up to 1 hour.
- Repeat bolus if cardiovascular instability persists (see BNF/local protocol).
๐ Examples of Drug Toxicity Treated
- Local anaesthetics (bupivacaine, lidocaine).
- Tricyclic antidepressants (TCAs).
- Calcium channel blockers (e.g. verapamil, diltiazem).
- Lipid-soluble beta-blockers (e.g. propranolol).
โ ๏ธ Interactions
- See BNF โ limited data; theoretical interference with IV drug delivery.
๐ Cautions
- See BNF โ ensure resuscitation equipment and ALS protocols in place.
๐ซ Contraindications
- See BNF โ generally avoided outside life-threatening emergencies due to uncertain efficacy and risks.
โ Side Effects
- Hypertriglyceridaemia ๐
- Acute pancreatitis ๐ฉบ
- Cholestasis and liver dysfunction (rare) ๐งช
๐ References